Diet-induced obesity and hepatic steatosis in L-Fabp / mice is abrogated with SF, but not PUFA, feeding and attenuated after cholesterol supplementation.
about
Fatty Acid Induced Remodeling within the Human Liver Fatty Acid-binding ProteinRecent insights into the biological functions of liver fatty acid binding protein 1Serum liver fatty acid binding protein levels correlate positively with obesity and insulin resistance in Chinese young adultsFatty acid transport protein 4 is dispensable for intestinal lipid absorption in miceStructural and functional analysis of fatty acid-binding proteins.Structural and functional interaction of fatty acids with human liver fatty acid-binding protein (L-FABP) T94A variantFatty acid-binding proteins: role in metabolic diseases and potential as drug targets.High dietary fat exacerbates weight gain and obesity in female liver fatty acid binding protein gene-ablated mice.PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid omega-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver DiseaseHepatic phenotype of liver fatty acid binding protein gene-ablated miceComputational prediction and experimental validation associating FABP-1 and pancreatic adenocarcinoma with diabetes.Silencing of FABP1 ameliorates hepatic steatosis, inflammation, and oxidative stress in mice with nonalcoholic fatty liver disease.Liver fatty acid-binding protein and obesity.Diet-induced alterations in intestinal and extrahepatic lipid metabolism in liver fatty acid binding protein knockout mice.Acetylcholinesterase (AChE) inhibition aggravates fasting-induced triglyceride accumulation in the mouse liverDifferent functions of intestinal and liver-type fatty acid-binding proteins in intestine and in whole body energy homeostasisSpecific role for acyl CoA:Diacylglycerol acyltransferase 1 (Dgat1) in hepatic steatosis due to exogenous fatty acids.Enterocyte fatty acid-binding proteins (FABPs): different functions of liver and intestinal FABPs in the intestine.Decreased body weight and hepatic steatosis with altered fatty acid ethanolamide metabolism in aged L-Fabp -/- mice.Loss of L-FABP, SCP-2/SCP-x, or both induces hepatic lipid accumulation in female miceInitial studies of the cytoplasmic FABP superfamilyPhenotypic divergence in two lines of L-Fabp-/- mice reflects substrain differences and environmental modifiers.Susceptibility of L-FABP-/- mice to oxidative stress in early-stage alcoholic liver.Liver fatty acid binding protein gene-ablation exacerbates weight gain in high-fat fed female miceLiver fatty acid binding protein (L-Fabp) modulates murine stellate cell activation and diet-induced nonalcoholic fatty liver disease.Altered hepatic triglyceride content after partial hepatectomy without impaired liver regeneration in multiple murine genetic models.Increased susceptibility to diet-induced gallstones in liver fatty acid binding protein knockout mice.Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver diseaseLiver fatty acid-binding protein (L-Fabp) modifies intestinal fatty acid composition and adenoma formation in ApcMin/+ mice.Direct comparison of mice null for liver or intestinal fatty acid-binding proteins reveals highly divergent phenotypic responses to high fat feeding.Fatty acid synthase mediates the epithelial-mesenchymal transition of breast cancer cells.Hepatic ATGL mediates PPAR-α signaling and fatty acid channeling through an L-FABP independent mechanism.Dietary fat sensing via fatty acid oxidation in enterocytes: possible role in the control of eating.Screening and identification of differentially expressed genes in goose hepatocytes exposed to free fatty acid.Ablating both Fabp1 and Scp2/Scpx (TKO) Induces Hepatic Phospholipid and Cholesterol Accumulation in High Fat-fed Mice.Perilipin 5 and Liver fatty acid binding protein function to restore quiescence in mouse hepatic stellate cells.The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis.Pyrazinamide induced hepatic injury in rats through inhibiting the PPARα pathway.
P2860
Q27670800-B5EC466F-707C-4CCC-AE4B-32479150B22DQ28268205-67FD3D56-925B-4F1A-84F5-2C84E993CCC4Q28279093-82100AAF-A7BF-455B-A919-7FD341CFEEF8Q28505425-4DBF61EF-F8CA-4FA5-A8AF-0BA3BAB8395EQ30373375-E0EAA0BE-83AE-490A-9051-E99E20AF4EF6Q33581953-87B26943-A83C-4845-84B3-7DA3DDDBDE1CQ33649348-064CD51D-1338-433D-841F-92D3AFDDA547Q33701882-FDAA538F-A45B-4854-ACB9-962833B64A0CQ33734125-C6357B5E-45FF-41FD-A2B0-6BDAD46F5A82Q33771768-C40C1260-B418-4A07-AEDE-DCBD9D64225BQ33798621-39534F61-89D9-4BA1-B954-B47CAF6F80BDQ33862990-F9217450-3FC8-4EF0-88A7-6D30BDC7E32EQ34120131-F545251B-3CAF-4C67-A373-EB6DE2AE34D7Q34418473-EAB93857-F80F-47ED-ACBC-1213FAABD2D8Q34466808-3E52A5C3-37C4-42C6-B380-1C4244BEB403Q34979929-B2A113E5-A755-4ADC-8925-4442D19CEFA6Q34989773-D2FB4D3B-D8C9-42E6-8B31-9E62C2311096Q35071134-A6F8D594-B4F9-4A6F-9402-05A8BC437B3CQ35839688-3FB42C74-4EA2-44A8-9095-F962800EF18BQ35911451-102B6746-7EF0-403F-968E-709D8BD646C5Q36160382-9FDD014E-1F32-426C-A515-BC26E25BEC99Q36174516-C3CC5BFE-A9DA-48ED-AD40-9CC5A703E99CQ36754807-803BB596-7A8E-40A9-91C4-53AB26644B73Q36808382-BD5918EC-1980-499D-8682-B33AF14E6C8CQ36881286-955A448C-C887-4198-8AAE-C9B224827E9BQ36960874-6C197087-23DB-40EF-A312-8D1EB660A778Q37151863-8F5A37A9-3F2E-41CB-A686-8B353A9CA255Q37171953-C96A80E5-D2FE-43EF-9F62-741A9A5938CDQ37216923-3A7450EF-EE1A-478D-9AC6-230364D87FB1Q37234028-52A45BA7-86F7-48E5-BF23-7A80BCECE511Q37576015-D32BDD17-FA24-48C6-88B1-5ADDE2A9F949Q37716343-91641151-5AF4-4728-99FD-2381F529375CQ37819529-DCD5FB63-B922-4575-A398-075D78141E1DQ42875970-147BF6A8-2DFB-45DC-8B85-94D873AF5C92Q47200557-DF925194-CC7A-4B68-BA25-7488AE5EB8C3Q47215914-C7C7DFDB-87B0-40D4-8EEE-4EFB3749B662Q50473358-61D766CD-C56E-45F3-B70C-323D2898F8BFQ53766284-93AEE382-6050-4CA6-AC55-4346056BD942
P2860
Diet-induced obesity and hepatic steatosis in L-Fabp / mice is abrogated with SF, but not PUFA, feeding and attenuated after cholesterol supplementation.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Diet-induced obesity and hepat ...... r cholesterol supplementation.
@en
Diet-induced obesity and hepat ...... r cholesterol supplementation.
@nl
type
label
Diet-induced obesity and hepat ...... r cholesterol supplementation.
@en
Diet-induced obesity and hepat ...... r cholesterol supplementation.
@nl
prefLabel
Diet-induced obesity and hepat ...... r cholesterol supplementation.
@en
Diet-induced obesity and hepat ...... r cholesterol supplementation.
@nl
P2093
P2860
P356
P1476
Diet-induced obesity and hepat ...... r cholesterol supplementation.
@en
P2093
Britni T Sternard
Elizabeth P Newberry
Jianyang Luo
Nicholas O Davidson
Susan M Kennedy
P2860
P304
P356
10.1152/AJPGI.00377.2007
P577
2007-11-21T00:00:00Z